30285-1
Zalcitabine [Susceptibility] by Genotype method
Active
Part Descriptions
LP21316-2 Zalcitabine
Zalcitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21316-2 Zalcitabine
Zalcitabine, also called dideoxycytidine, is a nucleoside analog reverse transcriptase inhibitor (NARTI) sold under the trade name Hivid.
Zalcitabine was the third antiretroviral to be approved by the Food and Drug Administration (FDA) for the treatment of HIV infection and AIDS, but sale and distribution has been discontinued since 2006.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
LP21316-2 Zalcitabine
Zalcitabine (2'-3'-dideoxycytidine, ddC), also called dideoxycytidine, is a nucleoside analog reverse transcriptase inhibitor (NARTI) sold under the trade name Hivid.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
LOINC Names Get Info
- Fully-Specified Name
- Zalcitabine:
Susc: Pt: Isolate: Ord: Genotyping - Long Common Name
- Zalcitabine [Susceptibility] by Genotype method
- Short Name
- Zalcitabine Islt Genotyp
- Display Name
- Zalcitabine Genotyping [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Zalcitabine
Part Model Get Info
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.66 (MAJ)
- Change Reason
- Corrected Scale from OrdQn to Ord because Genotyping does not produce a quantitative susceptibility result
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49660-4 | HIV susceptibility panel by Genotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41241-7 | ZalcitabineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Zalcitabin: |
| el-GR | Greek (Greece) | Ζαλσιταβίνη: Synonyms: ABXBACT Ord Pt Susc Απομονωμένο στέλεχος Γονοτύπηση Ζαλσιταβίνη |
| es-AR | Spanish (Argentina) | zalcitabina: |
| es-ES | Spanish (Spain) | Zalcitabina: |
| es-MX | Spanish (Mexico) | Zalcitabina: |
| et-EE | Estonian (Estonia) | Salkitabiin: Synonyms: Isolaat Järgarvuline Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Zalcitabine: |
| fr-FR | French (France) | Zalcitabine: |
| fr-BE | French (Belgium) | Zalcitabine: |
| it-IT | Italian (Italy) | Zalcitabina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità al genotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 잘시타빈: |
| nl-NL | Dutch (Netherlands) | zalcitabine: |
| pl-PL | Polish (Poland) | Zalcytabina: Synonyms: wrażliwość (mikroorganizmów) |
| pt-BR | Portuguese (Brazil) | Zalcitabina: Synonyms: HIVID; |
| ru-RU | Russian (Russian Federation) | Залцитабин: Synonyms: Вирусного генотипа чувствительность Порядковый Точка во времени; |
| tr-TR | Turkish (Turkey) | Zalcitabine: |
| zh-CN | Chinese (China) | 扎西他滨: Synonyms: ddC; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://